-
Company Profile
Heidelberger Druckmaschinen AG – Company Profile
Heidelberger Druckmaschinen AG (Heidelberg) is a provider of solutions to the print media industry. The company's major products include digital printing, narrow web printing, offset printing, screen printing and inline flexo, remarketed equipment, cutting, die-cutting and embossing, folding, inspection, folding carton gluing and hot foil stamping. Its major services include print site contracts, technical services, performance services, service agreement, parts and labor services, remote services, digital platform training and consulting services. Heidelberg provides its products and services to vehicle manufacturing,...
Add to Basket -
Company Profile
HeidelbergCement AG – Company Profile
Heidelberg Materials AG (Heidelberg), formerly HeidelbergCement AG, is a provider of building materials. The company carries out the production and distribution of cement and aggregates including gravel, sand, and crushed rock. It also produces ready-mixed concrete, asphalt, and other building materials such as gypsum and limestone; and carries out the trading of cement, solid fuels, clinker, and other building materials by sea. It trades cement and coal by sea across the globe. Heidelberg serves the construction of infrastructure, houses and...
Add to Basket -
Product Insights
Heidelberg Engineering GmbH, United States Revenue
GlobalData, the industry analysis specialist, has released its latest report: Heidelberg Engineering GmbH, United States Revenue. The medical devices sector is typified by frequent change and innovation in available devices, in response to demand from healthcare for ever more effective therapies and increased competition. As a result, the sector has seen the emergence of start-up medtech companies who are producing the most innovative and cutting-edge solutions to problems and issues faced by the healthcare industry. Most of these companies are...
-
Company Profile
Haci Omer Sabanci Holding AS – Company Profile
Haci Omer Sabanci Holding AS (Sabancı Holding) is an industrial and financial conglomerate. It carries out banking, insurance, energy, cement, retail and industrials business operations. The group has partnerships with various multinational companies including Ageas, Aviva, Bridgestone, Carrefour, E.ON, Heidelberg Cement, Marubeni, and Philip Morris. The group offers banking services through AKBank, and insurance services through Aksigorta and Avivasa Emeklilik ve Hayat, and carries out cement operations through Akcansa and Cimsa, and industrial operations through Kordsa, Brisa, Temsa, and Temsa...
Add to Basket -
Product Insights
Bile Duct Cancer (Cholangiocarcinoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Bile Duct Cancer Pipeline Drugs Market Report Overview Bile duct cancer (cholangiocarcinoma) are tumors that occur in the bile duct. Symptoms include discomfort in the tummy area (abdomen), loss of appetite, high temperatures (fevers), and weight loss. Treatment includes chemotherapy and radiation therapy. The Bile Duct Cancer drugs in development market research report provides comprehensive information on the therapeutics under development for Bile Duct Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of...
-
Product Insights
Multiple Myeloma (Kahler Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Multiple Myeloma Pipeline Products Market Report Overview Multiple myeloma is a type of cancer that is caused by malignant plasma cells that proliferate in the bone marrow and produce abnormally high amounts of a special protein. The exact cause of multiple myeloma is not clear. It mainly affects older adults. Symptoms include anemia, bleeding, nerve damage, skin lesions, bone tenderness or pain, and kidney failure. Treatment includes chemotherapy, radiation, immunosuppression, and surgery. The Multiple Myeloma Drugs in Development market research...
-
Product Insights
Colorectal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Colorectal Cancer Pipeline Products Market Report Overview Colorectal cancer starts in the colon or the rectum. It begins as a growth called a polyp on the inner lining of the colon or rectum. Symptoms include abdominal pain and tenderness in the lower abdomen, blood in the stool, diarrhea, constipation, change in bowel habits, narrow stools, and weight loss with no known reasons. Risk factors for colorectal cancer include smoking, heavy alcohol use, inflammatory bowel disease (IBD), and family history. Treatment...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – HDP-101
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry HDP-101 Drug Details HDP-101 is under development for the treatment of relapsed/refractory multiple myeloma,...
-
Product Insights
Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Prostate cancer usually occurs in older men. Its symptoms include problems while urinating, decreased force in the stream of urine, blood in the urine, pain in the lower back, hips, or thighs, bone pain, and erectile dysfunction. The Prostate Cancer pipeline market research report provides comprehensive information on the therapeutics under development for Prostate Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the...
-
Product Insights
Herpes Labialis (Oral Herpes) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Oral herpes is an infection of the lips, mouth, or gums due to the herpes simplex virus. Its symptoms include sore throat, fever, swollen glands, and painful swallowing. The Herpes Labialis pipeline market research report provides comprehensive information on the therapeutics under development for Herpes Labialis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research...